Skip to main content
NCBI home page
The BMJ logoLink to The BMJ
. 1990 Jun 30;300(6741):1667–1668. doi: 10.1136/bmj.300.6741.1667

Biochemical neonatal screening.

B Modell 1
PMCID: PMC1663288  PMID: 2202440

Full text

PDF
1667

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ballabio A., Gibbs R. A., Caskey C. T. PCR test for cystic fibrosis deletion. Nature. 1990 Jan 18;343(6255):220–220. doi: 10.1038/343220a0. [DOI] [PubMed] [Google Scholar]
  2. Dellamonica C., Robert J. M., Cotte J., Collombel C., Dorche G. Systematic neonatal screening for Duchenne muscular dystrophy. Lancet. 1978 Nov 18;2(8099):1100–1100. doi: 10.1016/s0140-6736(78)91836-6. [DOI] [PubMed] [Google Scholar]
  3. Gardner-Medwin D. Recognising and preventing Duchenne muscular dystrophy. Br Med J (Clin Res Ed) 1983 Oct 15;287(6399):1083–1084. doi: 10.1136/bmj.287.6399.1083. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Grover R. Newborn screening for sickle cell disease and other hemoglobinopathies. Newborn screening in New York City. Pediatrics. 1989 May;83(5 Pt 2):819–822. [PubMed] [Google Scholar]
  5. Harvey T. C., Raichle M. E., Winterborn M. H., Jensen J., Lassen N. A., Richardson N. V., Bradwell A. R. Effect of carbon dioxide in acute mountain sickness: a rediscovery. Lancet. 1988 Sep 17;2(8612):639–641. doi: 10.1016/s0140-6736(88)90465-5. [DOI] [PubMed] [Google Scholar]
  6. Hoffman E. P., Brown R. H., Jr, Kunkel L. M. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell. 1987 Dec 24;51(6):919–928. doi: 10.1016/0092-8674(87)90579-4. [DOI] [PubMed] [Google Scholar]
  7. McNeil T. F., Sveger T., Thelin T. Psychosocial effects of screening for somatic risk: the Swedish alpha 1 antitrypsin experience. Thorax. 1988 Jul;43(7):505–507. doi: 10.1136/thx.43.7.505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Newton C. R., Heptinstall L. E., Summers C., Super M., Schwarz M., Anwar R., Graham A., Smith J. C., Markham A. F. Amplification refractory mutation system for prenatal diagnosis and carrier assessment in cystic fibrosis. Lancet. 1989 Dec 23;2(8678-8679):1481–1483. doi: 10.1016/s0140-6736(89)92931-0. [DOI] [PubMed] [Google Scholar]
  9. Riordan J. R., Rommens J. M., Kerem B., Alon N., Rozmahel R., Grzelczak Z., Zielenski J., Lok S., Plavsic N., Chou J. L. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science. 1989 Sep 8;245(4922):1066–1073. doi: 10.1126/science.2475911. [DOI] [PubMed] [Google Scholar]
  10. Smith R. A., Rogers M., Bradley D. M., Sibert J. R., Harper P. S. Screening for Duchenne muscular dystrophy. Arch Dis Child. 1989 Jul;64(7):1017–1021. doi: 10.1136/adc.64.7.1017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Udall J. N., Jr, Dixon M., Newman A. P., Wright J. A., James B., Bloch K. J. Liver disease in alpha 1-antitrypsin deficiency. A retrospective analysis of the influence of early breast- vs bottle-feeding. JAMA. 1985 May 10;253(18):2679–2682. doi: 10.1001/jama.253.18.2679. [DOI] [PubMed] [Google Scholar]
  12. Wilcken B., Chalmers G. Reduced morbidity in patients with cystic fibrosis detected by neonatal screening. Lancet. 1985 Dec 14;2(8468):1319–1321. doi: 10.1016/s0140-6736(85)92623-6. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES